BGI Genomics Co Ltd (SHE:300676) — Market Cap & Net Worth
Market Cap & Net Worth: BGI Genomics Co Ltd (300676)
BGI Genomics Co Ltd (SHE:300676) has a market capitalization of $2.23 Billion (CN¥15.21 Billion) as of September 16, 2026. Listed on the SHE stock exchange, this China-based company holds position #5799 globally and #1078 in its home market, demonstrating a -1.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BGI Genomics Co Ltd's stock price CN¥36.36 by its total outstanding shares 418317075 (418.32 Million). Also see 300676 current and non-current assets for a full breakdown of the balance sheet.
BGI Genomics Co Ltd Market Cap History: 2017 to 2026
BGI Genomics Co Ltd's market capitalization history from 2017 to 2026. Data shows growth from $12.29 Billion to $2.23 Billion (7.36% CAGR). Also see how efficiently does BGI Genomics Co Ltd generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
BGI Genomics Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.14 Trillion | 0.19% | #76 of 100 |
Weight: BGI Genomics Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BGI Genomics Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BGI Genomics Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BGI Genomics Co Ltd share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.75x
BGI Genomics Co Ltd's market cap is 0.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $12.29 Billion | $2.10 Billion | $398.09 Million | 5.86x | 30.86x |
| 2018 | $3.56 Billion | $2.54 Billion | $386.65 Million | 1.40x | 9.22x |
| 2019 | $4.09 Billion | $2.80 Billion | $276.33 Million | 1.46x | 14.79x |
| 2020 | $7.65 Billion | $8.40 Billion | $2.09 Billion | 0.91x | 3.66x |
| 2021 | $5.24 Billion | $6.77 Billion | $1.46 Billion | 0.77x | 3.59x |
| 2022 | $3.10 Billion | $7.05 Billion | $802.77 Million | 0.44x | 3.86x |
| 2023 | $2.93 Billion | $4.35 Billion | $92.90 Million | 0.67x | 31.54x |
| 2024 | $2.57 Billion | $3.87 Billion | -$902.69 Million | 0.66x | N/A |
| 2025 | $2.78 Billion | $3.71 Billion | -$616.66 Million | 0.75x | N/A |
Competitor Companies of 300676 by Market Capitalization
Companies near BGI Genomics Co Ltd in the global market cap rankings as of September 16, 2026. Review tangible net worth ratio of BGI Genomics Co Ltd to assess the quality of the company's equity after excluding intangible assets.
Key companies related to BGI Genomics Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
BGI Genomics Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, BGI Genomics Co Ltd's market cap moved from $12.29 Billion to $ 2.23 Billion, with a yearly change of 7.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.23 Billion | -19.84% |
| 2025 | CN¥2.78 Billion | +8.08% |
| 2024 | CN¥2.57 Billion | -12.31% |
| 2023 | CN¥2.93 Billion | -5.54% |
| 2022 | CN¥3.10 Billion | -40.84% |
| 2021 | CN¥5.24 Billion | -31.50% |
| 2020 | CN¥7.65 Billion | +87.25% |
| 2019 | CN¥4.09 Billion | +14.70% |
| 2018 | CN¥3.56 Billion | -71.00% |
| 2017 | CN¥12.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of BGI Genomics Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.23 Billion USD |
| MoneyControl | $2.23 Billion USD |
| MarketWatch | $2.23 Billion USD |
| marketcap.company | $2.23 Billion USD |
| Reuters | $2.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BGI Genomics Co Ltd
BGI Genomics Co., Ltd. engages in the provision of research services, comprehensive precision medicine testing solutions, and health management services in China and internationally. The company offers DNA sequencing services comprising plant/animal/microbial whole genome re-sequencing and de novo sequencing; human whole genome sequencing, long-read human whole genome resequencing, and whole exom… Read more